Sign in
IBO Stock Price, Chart, Stats & News
Impact BioMedical Inc.
Save
Impact BioMedical Inc. (IBO) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
IBO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -4803.13% |
Operating margin | -10362.50% |
Pretax margin | -45156.25% |
Net margin | -36993.75% |
Effective tax rate | 17.89% |
ROA | -68.01% |
ROE | 831.03% |
D/E | – |
Interest coverage ratio | 4.18x |
IBO valuation
P/E | – |
P/S | 224.53x |
P/B | 1.44x |
P/CF | -15.00x |
P/FCF | -5.94x |
P/OCF | -15.00x |
PEG | -0.02x |
EV multiple | -2.30x |
About
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption.
Similar securities
Based on sector and market capitalization
Report issue